Skip to content
Search AI Powered

Latest Stories

NPA ballot result: Pharmacy owners vote to withdraw services if funding uplift isn’t met

NPA ballot result: Pharmacy owners vote to withdraw services if funding uplift isn’t met

Nearly all pharmacy owners in England who participated in the NPA ballot voted to reduce their opening hours to the minimum required by their contract 

Community pharmacies are bracing themselves to withdraw services from patients after an industry ballot supported plans for major action unless the government provided a significant increase in funding for the sector.


The National Pharmacy Association (NPA) on Tuesday (12) announced the results of an unprecedented collective action ballot in which nearly all pharmacy owners, who participated in the ballot, voted to limit their services, insisting that a lack of additional funding is jeopardising patients health and safety.

Over 63 per cent of NPA members in England, Wales and Northern Ireland took part in the ballot– representing 3,049 independent community pharmacies in England alone, or 3,399 with Wales and Northern Ireland included.

Nearly 98 per cent of pharmacy owners in England voted to reduce their opening hours to the minimum required by their contract. This could result in fewer pharmacies remaining open during evenings and weekends.

More than 93 per cent voted to stop offering “unfunded” free home deliveries of medicines, and over 96 per cent voted to withdraw from locally commissioned services, including certain addiction support, emergency contraception, and stop smoking services.

Almost all voted to refuse cooperation with data requests from other healthcare providers beyond what is necessary for patient safety and contractual requirements.

The majority of pharmacy owners also voted to stop supplying free monitored dose systems (medicine packs) that are not funded by the NHS, except those covered by the Disability Discrimination Act.

Commenting on the ballot result, NPA chair Nick Kaye said: “Pharmacies don’t want to reduce services but we will be left with no option but to suggest that pharmacy owners should consider acting on the clear ballot results if government does not act to protect this vital and much-loved part of our health service.”

He highlighted that pharmacies have been forced into an “untenable position” by a decade of underfunding, leading to a record number of closures.

According to NPA, 700 pharmacies have shut down in England alone in the last two years.

The association has expressed concern that the Budget will push more pharmacies on the verge of closure.

“The sense of anger among pharmacy owners has been intensified exponentially by the Budget – with its hike in National Insurance employers’ contributions and the unfunded National Living Wage increase – which has tipped even more pharmacies to the brink,” Kaye said.

It has urged the government to meet and discuss a new funding deal for pharmacies and modernisation of pharmacy with a funded expansion of clinical services.

Last month, at the Pharmacy Business Awards, pharmacy minister Stephen Kinnock said contract negotiations are going to be “moved forward as rapidly as possible” without giving a definitive date on when the new contract will be announced.

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less